Respiratory Pathogens at Exacerbation in Chronic Bronchitis With Airway Bacterial Colonisation: A Cohort Study

ABSTRACT Background and Objective COPD and bronchiectasis are common causes of morbidity, particularly around exacerbation. Colonisation with respiratory pathogens can increase the frequency and severity of exacerbations. However, bacterial and viral presence at exacerbation in people with airway co...

Full description

Bibliographic Details
Published in:	The Clinical Respiratory Journal
Main Authors:	Thomas L. Jones, Claire Roberts, Scott Elliott, Sharon Glaysher, Ben Green, Janis K. Shute, Anoop J. Chauhan
Format:	Article
Language:	English
Published:	Wiley 2024-08-01
Subjects:	bacteria bronchiectasis COPD exacerbation Haemophilus influenza infection
Online Access:	https://doi.org/10.1111/crj.13811

Similar Items

Impact of bronchiectasis on the frequency and severity of respiratory exacerbations in COPD
by: Labaki WW, et al.
Published: (2018-07-01)

Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort
by: Kim EK, et al.
Published: (2021-11-01)

NTHi killing activity is reduced in COPD patients and is associated with a differential microbiome
by: Vancheswaran Gopalakrishnan, et al.
Published: (2025-01-01)

Sputum Microbiota Compositions Correlate With Metabolome and Clinical Outcomes of COPD‐Bronchiectasis Association: A Prospective Cohort Study
by: Zhen‐feng He, et al.
Published: (2025-08-01)

Loss of cPLA2α function attenuates inflammation and epithelial thickening in a mouse model of Haemophilus influenzae-mediated COPD exacerbation
by: Brice Lagrange, et al.
Published: (2026-01-01)

Effectiveness of influenza vaccination in preventing severe COPD exacerbations and pneumonia before, during, and after the COVID-19 pandemic: a retrospective cohort studyResearch in context
by: Sophia Eilat Tsanani, et al.
Published: (2025-06-01)

Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis
by: Hung-Yu Huang, et al.
Published: (2023-02-01)

Clinical epidemiology and impact of Haemophilus influenzae airway infections in adults with cystic fibrosis
by: R. Benson Weyant, et al.
Published: (2024-10-01)

Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study
by: Ilaria Galgani, et al.
Published: (2022-05-01)

Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease
by: Fathia G. Jaat, et al.
Published: (2018-05-01)

Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza—A Territory-Wide Study
by: Wang-Chun Kwok, et al.
Published: (2024-06-01)

Long-term immunogenicity and safety of a non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine: 4-year follow-up of a phase 1 multicentre trial
by: Philippe De Smedt, et al.
Published: (2021-12-01)

Previous Moraxella catarrhalis Infection as a Risk Factor of COPD Exacerbations Leading to Hospitalization
by: Kyoko Yagyu, et al.
Published: (2025-05-01)

Comparative Evaluation of Systemic Inflammatory Indices in Bronchiectasis: Identification of Exacerbation Phenotype
by: Selda Günaydın, et al.
Published: (2026-06-01)

Non-typeable Haemophilus Influenzae detection in the lower airways of patients with lung cancer and chronic obstructive pulmonary disease
by: Krishna B. Sriram, et al.
Published: (2018-04-01)

High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk
by: Wang Chun Kwok, et al.
Published: (2024-02-01)

Understanding the effects of Haemophilus influenzae colonization on bronchiectasis: a retrospective cohort study
by: Seo-Hee Yang, et al.
Published: (2024-01-01)

Mortality and exacerbations in bronchiectasis patients with carbapenem-resistant Pseudomonas aeruginosa isolation: a long-term retrospective cohort study
by: Jibo Sun, et al.
Published: (2025-05-01)

Baseline neutrophil-to-lymphocyte ratio as a predictor of response to hospitalized bronchiectasis exacerbation risks
by: Wang Chun Kwok, et al.
Published: (2024-12-01)

Bronchiectasis in patients with chronic obstructive pulmonary disease
by: Milesh Jung Sijapati, et al.
Published: (2018-09-01)

Bronchiectasis in COPD patients: more than a comorbidity?
by: Martinez-Garcia MA, et al.
Published: (2017-05-01)

Precise pathogen detection and clinical characterization of bronchiectasis
by: Qinghua Gao, et al.
Published: (2025-09-01)

Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease
by: Terence Ho, et al.
Published: (2022-01-01)

No evidence for additional systemic eosinophil mobilization during exacerbations in patients with COPD and chronic bronchitis but no allergy
by: Anders Andersson, et al.
Published: (2025-05-01)

Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan
by: Akihiko Hagiwara, et al.
Published: (2024-12-01)

Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
by: Lotte C. Terpstra, et al.
Published: (2022-12-01)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
by: Russell REK, et al.
Published: (2019-05-01)

Acute exacerbations of COPD
by: W MaxNee
Published: (2003-05-01)

Roles of C-reactive protein and its composite index in predicting acute exacerbation of bronchiectasis
by: Jun Zhang, et al.
Published: (2025-08-01)

AI based prediction of severe exacerbation in Asian bronchiectasis patients using the KMBARC registry
by: Bumhee Yang, et al.
Published: (2026-02-01)

Magnesium Administration For COPD Exacerbation: A Systematic Review and Meta-analysis
by: Hala Alzaid, et al.
Published: (2021-07-01)

Understanding the Gaps in the Reporting of COPD Exacerbations by Patients: A Review
by: Paul Jones, et al.
Published: (2024-12-01)

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
by: Hyo Jin Lee, et al.
Published: (2024-01-01)

Impact of antibiotics on acute exacerbations of COPD
by: Wafaa Ali Hassan, et al.
Published: (2015-07-01)

Determinants of disease severity in pediatric protracted bacterial bronchitis
by: Evrim Hepkaya, et al.
Published: (2026-03-01)

The Significance of Density Measurement and the Modified Bhalla and Reiff Scores in Predicting Exacerbations and Hospital Admissions in Cystic Fibrosis Patients
by: Oğuz Karcıoğlu, et al.
Published: (2025-04-01)

Antibiotic Prescriptions in Hospitalized Patients with an Exacerbation COPD and a Proven Influenza or RS Virus Infection
by: van Brummelen S, et al.
Published: (2022-06-01)

COPD exacerbation: factors influencing hospitalization duration.
by: K. Yu. Gashynova
Published: (2015-03-01)

COPD exacerbation: factors influencing hospitalization duration
by: Gashynova K.Yu.
Published: (2015-03-01)

The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
by: L.C. Terpstra, et al.
Published: (2022-12-01)